Cargando…

A pro B cell population forms the apex of the leukemic hierarchy in Hoxa9/Meis1-dependent AML

Relapse is a major challenge to therapeutic success in acute myeloid leukemia (AML) and can be partly associated with heterogeneous leukemic stem cell (LSC) properties. In the murine Hoxa9/Meis1-dependent (H9M) AML model, LSC potential lies in three defined immunophenotypes, including Lin(−)cKit(+)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lieske, Anna, Agyeman-Duah, Eric, Selich, Anton, Dörpmund, Nicole, Talbot, Steven R., Schambach, Axel, Maetzig, Tobias
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883166/ https://www.ncbi.nlm.nih.gov/pubmed/36517672 http://dx.doi.org/10.1038/s41375-022-01775-y

Ejemplares similares

A Multiplex CRISPR-Screen Identifies PLA2G4A as Prognostic Marker and Druggable Target for HOXA9 and MEIS1 Dependent AML
por: Hassan, Jacob Jalil, et al.
Publicado: (2021)

Competitive sgRNA Screen Identifies p38 MAPK as a Druggable Target to Improve HSPC Engraftment
por: Klatt, Denise, et al.
Publicado: (2020)

Real-Time Characterization of Clonal Fate Decisions in Complex Leukemia Samples by Fluorescent Genetic Barcoding
por: Maetzig, Tobias, et al.
Publicado: (2022)

Conditionally immortalised leukaemia initiating cells co-expressing Hoxa9/Meis1 demonstrate microenvironmental adaptation properties ex vivo while maintaining myelomonocytic memory
por: Stahlhut, Maike, et al.
Publicado: (2021)

HOXA9/MEIS1 targets in leukemia: reinforced signaling networks and therapeutic opportunities
por: Zhou, Xinyue, et al.
Publicado: (2022)

The Deficiency of Tumor Suppressor Prep1 Accelerates the Onset of Meis1- Hoxa9 Leukemogenesis
por: Dardaei, Leila, et al.
Publicado: (2014)

Hoxa2 Selectively Enhances Meis Binding to Change a Branchial Arch Ground State
por: Amin, Shilu, et al.
Publicado: (2015)

Npm1 haploinsufficiency in collaboration with MEIS1 is sufficient to induce AML in mice
por: Muranyi, Andrew, et al.
Publicado: (2022)

High-Resolution Pictures of AML Hierarchies
por: Tesio, Melania
Publicado: (2019)

Expression of meis and hoxa11 in dipnoan and teleost fins provides new insights into the evolution of vertebrate appendages
por: Langellotto, Fernanda, et al.
Publicado: (2018)

Mutated NPM1 in combination with overexpression of Meis1 or Hoxa9 is not sufficient to induce acute myeloid leukemia
por: Wiktorin, Hanna Grauers, et al.
Publicado: (2016)

Immunotherapy-Based Targeting and Elimination of Leukemic Stem Cells in AML and CML
por: Valent, Peter, et al.
Publicado: (2019)

Meis2 as a critical player in MN1-induced leukemia
por: Lai, C K, et al.
Publicado: (2017)

MOZ is critical for the development of MOZ/MLL fusion–induced leukemia through regulation of Hoxa9/Meis1 expression
por: Katsumoto, Takuo, et al.
Publicado: (2022)

Hoxa9/meis1-transgenic zebrafish develops acute myeloid leukaemia-like disease with rapid onset and high penetrance
por: Wang, Wei, et al.
Publicado: (2022)

HOXA11 plays critical roles in disease progression and response to cytarabine in AML
por: Fu, Jen-Fen, et al.
Publicado: (2021)

Gammaretroviral Vectors: Biology, Technology and Application
por: Maetzig, Tobias, et al.
Publicado: (2011)

Hoxa9 and Meis1 Cooperatively Induce Addiction to Syk Signaling by Suppressing miR-146a in Acute Myeloid Leukemia
por: Mohr, Sebastian, et al.
Publicado: (2017)

The SQSTM1-NUP214 fusion protein interacts with Crm1, activates Hoxa and Meis1 genes, and drives leukemogenesis in mice
por: Lavau, Catherine P., et al.
Publicado: (2020)

The methyltransferase G9a regulates HoxA9-dependent transcription in AML
por: Lehnertz, Bernhard, et al.
Publicado: (2014)

An LSC epigenetic signature is largely mutation independent and implicates the HOXA cluster in AML pathogenesis
por: Jung, Namyoung, et al.
Publicado: (2015)

Low-dose salinomycin induces anti-leukemic responses in AML and MLL
por: Roulston, Gary D.R., et al.
Publicado: (2016)

Mei : per flauto solo (1962)
por: Fukushima, Kazuo
Publicado: (1966)

miR-196b directly targets both HOXA9/MEIS1 oncogenes and FAS tumour suppressor in MLL-rearranged leukaemia
por: Li, Zejuan, et al.
Publicado: (2012)

Lentiviral Fluorescent Genetic Barcoding for Multiplex Fate Tracking of Leukemic Cells
por: Maetzig, Tobias, et al.
Publicado: (2017)

Contribution of CTCF binding to transcriptional activity at the HOXA locus in NPM1-mutant AML cells
por: Ghasemi, Reza, et al.
Publicado: (2020)

Coexpression profile of leukemic stem cell markers for combinatorial targeted therapy in AML
por: Haubner, S., et al.
Publicado: (2018)

β-catenin and γ-catenin are dispensable for T lymphocytes and AML leukemic stem cells
por: Zhao, Xin, et al.
Publicado: (2020)

Distinct regulation of c-myb gene expression by HoxA9, Meis1 and Pbx proteins in normal hematopoietic progenitors and transformed myeloid cells
por: Dassé, E, et al.
Publicado: (2012)

Tumor-Suppressive Role of microRNA-202-3p in Hepatocellular Carcinoma Through the KDM3A/HOXA1/MEIS3 Pathway
por: Zhang, Yijie, et al.
Publicado: (2021)

Structural insights reveal the specific recognition of meiRNA by the Mei2 protein
por: Shen, Siyuan, et al.
Publicado: (2022)

Clonal competition within complex evolutionary hierarchies shapes AML over time
por: Sandén, Carl, et al.
Publicado: (2020)

Publisher Correction: miR-196b directly targets both HOXA9/MEIS1 oncogenes and FAS tumour suppressor in MLL-rearranged leukaemia
por: Li, Zejuan, et al.
Publicado: (2018)

Genome-wide co-occupancy of AML1-ETO and N-CoR defines the t(8;21) AML signature in leukemic cells
por: Trombly, Daniel J, et al.
Publicado: (2015)

Cytokine Selection of MSC Clones with Different Functionality
por: Selich, Anton, et al.
Publicado: (2019)

Umbilical cord as a long-term source of activatable mesenchymal stromal cells for immunomodulation
por: Selich, Anton, et al.
Publicado: (2019)

My mentors (Dascălii mei)
por: Bârsu, Cristian
Publicado: (2013)

Meis: New friends of Pax
por: Schulte, Dorothea
Publicado: (2014)

MEIS1 in Hematopoiesis and Cancer. How MEIS1-PBX Interaction Can Be Used in Therapy
por: Blasi, Francesco, et al.
Publicado: (2021)

Mixed lineage leukaemia histone methylases 1 collaborate with ERα to regulate HOXA10 expression in AML
por: Yao, Jie, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_roachqba1qjsf8j7f93dg7r943